DCIS and invasive carcinoma

A report can contain both diagnoses if one part remains within ducts and another part has breached the duct boundary. The invasive component then guides cancer staging and may alter surgery and additional treatment.

Under the microscope, the pathologist looks for abnormal cells beyond the basement membrane that surrounds a duct. DCIS alone lacks that invasion. Microinvasion means only a very small focus has crossed the boundary, but it is still recorded as invasion rather than pure DCIS.

A needle biopsy samples a limited area. Occasionally, surgery discovers invasion that was not visible in the biopsy cores. This does not mean the biopsy caused spread; the larger surgical sample simply allows more of the abnormal area to be examined.

Ask whether your current diagnosis is pure DCIS, DCIS with suspected microinvasion, or DCIS alongside confirmed invasive carcinoma. Clarify which finding came from imaging, which came from biopsy, and whether the surgical specimen could provide further information.

For pure DCIS, care usually focuses on removing the affected breast tissue, with radiotherapy or hormone therapy discussed in selected settings. Confirmed invasion can prompt assessment of lymph nodes and tumour markers as well as decisions about systemic treatment. Your team should tie each recommendation to the final pathology.

Request prompt assessment for a new breast or underarm lump, bloody nipple discharge, new nipple inversion, skin dimpling, or persistent breast redness. These signs need examination, but they cannot by themselves establish whether disease is in situ or invasive.

Once a biopsy or operation has been performed, rapidly increasing swelling, bleeding that continues despite firm pressure, chest pain, or breathing difficulty requires urgent help. Fever, worsening wound pain, spreading redness, or pus should be reported promptly to the surgical team.

Ask the breast specialist to identify the exact sentence that confirms or excludes invasion, explain whether lymph-node assessment is planned, and describe how the answer would change treatment. Also ask when final surgical pathology will replace the preliminary biopsy diagnosis.